ArticleCancer causes & control : CCC2026
Longitudinal associations of cardiorespiratory fitness and physical activity with changes in cognitive function in breast cancer patients undergoing chemotherapy: a prospective matched-control study.
Article in Cancer causes & control : CCC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeCancer-related cognitive impairment (CRCI) is a common concern among breast cancer (BC) patients receiving chemotherapy, yet predictors of short-term cognitive change remain unclear. This study examined whether baseline cardiorespiratory fitness (CRF) and moderate-to-vigorous physical activity (MVPA) moderate changes in objectively assessed cognitive function from pre- to post-chemotherapy in BC patients, compared with age-matched healthy controls.
methodsThis prospective study included assessments at baseline (pre-chemotherapy) and approximately a five-month follow-up (post-chemotherapy). Participants were BC patients with stage I-III disease initiating chemotherapy and age-matched healthy controls. Cognitive function was assessed using the NIH Remote Cognition Toolbox (episodic memory, working memory, language/reading, verbal learning). CRF was measured using a remotely administered 6-min walk test, and MVPA was assessed via accelerometry. Linear mixed-effects models tested group × time × predictor (baseline CRF or MVPA) effects, adjusting for anxiety, depression, and menopausal status.
resultsFifty-five participants were included (BC: n = 32; controls: n = 23). Episodic memory improved over time in both groups (β = 4.69, p = 0.031). Higher baseline CRF was associated with better verbal learning (β = 0.02, p = 0.023), but neither CRF nor MVPA predicted cognitive change over time (all three-way interactions p ≥ 0.05). BC patients scored lower than controls at baseline on working memory and language/reading, while verbal learning improved more in BC patients. BC patients also showed greater declines in MVPA over time.
findingsNo short-term cognitive decline was observed from pre-chemotherapy to approximately 5 months post-chemotherapy. Higher baseline fitness and physical activity were associated with better cognitive performance but did not predict cognitive change. Longer follow-up is needed to clarify treatment-related cognitive trajectories.
Indexed as
Identifiers
41981302What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.